1202 ORAL ANTI-CD3 IMMUNOTHERAPY FOR HCV-NON-RESPONDERS IS SAFE, PROMOTES REGULATORY T CELLS, AND DECREASES VIRAL LOAD AND LIVER ENZYME LEVELS: RESULTS OF A PHASE-2a PLACEBO-CONTROLLED TRIAL
Halota, W., Ferenzi, P., Kozielewicz, D., Dybowska, D., Lisovoder, N., Samira, S., Shalit, I., Ellis, R., Ilan, Y.Volume:
58
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(13)61203-9
Date:
April, 2013
File:
PDF, 65 KB
english, 2013